The board of directors of Keymed Biosciences Inc. announced that Dr. Dong LYU has tendered his resignation from the office of a non-executive Director of the Company with effect from March 29, 2022. Dr. Dong LYU resigned from his position in order to devote more time to pursue his other business engagements and has confirmed that he has no claim against the Company in respect of his resignation and has no disagreement with the Board.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
34.9 HKD | -0.14% | +17.71% | -28.92% |
Apr. 12 | Keymed Biosciences Advances Solid Tumors Drug With First Patient Study | MT |
Mar. 27 | KeyMed Biosciences’ Attributable Loss Widens in 2023 | MT |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-28.92% | 1.24B | |
-2.31% | 103B | |
+0.56% | 95.71B | |
+1.69% | 22.02B | |
-17.37% | 20.9B | |
-9.30% | 17.85B | |
-41.01% | 16.21B | |
-14.85% | 15.52B | |
+3.21% | 13.86B | |
+33.54% | 12.04B |
- Stock Market
- Equities
- 2162 Stock
- News Keymed Biosciences Inc.
- Keymed Biosciences Inc. Announces Resignation of Dong Lyu as Non-Executive Director